Pharma Proff

Post-Operative Pain Therapeutics – Pipeline Analysis , Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by Pharma Proff, post-operative pain therapeutics currently exhibits a proliferating pipeline with 10+ therapeutic candidates.

Request to Get Sample Pages at: http://bit.ly/2T0vlpE

Epic , Akorn, Inc , Therapeutics, Inc., DURECT Corporation , and Therapeutics are some of the major players involved in the development of therapeutics for the treatment of .

Prostatitis Therapeutics – Pipeline Analysis , Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by , prostatitis therapeutics currently exhibits a proliferating pipeline with 12+ therapeutic candidates.

Request to Get Sample Pages at: http://bit.ly/2QvEFjB

Aquinox Pharmaceuticals, Inc. , AbbVie , Pfizer , Kissei Pharmaceutical Co Ltd , The Janssen Pharmaceutical Companies of Johnson & Johnson and Novartis are some of the key players involved in the development of therapeutic drugs indicated for the treatment of .

Cushing’s Syndrome Therapeutics – Pipeline Analysis, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments” published by Pharma Proff, Cushing’s syndrome therapeutics currently exhibits a proliferating pipeline with 15+ therapeutic candidates.

Request to Get Sample Pages at: http://bit.ly/2sshZHQ

Some key players involved in the development of ’s include Novartis,
AstraZeneca, Diurnal Ltd , Corcept Therapeutics , Crinetics Pharmaceuticals ., Strongbridge Biopharma plc.

β-Site Aβ Cleaving Enzyme or Beta-Secretase (BACE) Inhibitors – Pipeline Analysis , Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by , BACE inhibitors currently exhibit a proliferating pipeline with 15+ therapeutic candidates.

Request to Get Sample Pages at:http://bit.ly/2ImnQ5M

β-Site Aβ or - ( )

Sarcopenia Therapeutics – Pipeline Analysis , Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by Pharma Proff, sarcopenia therapeutics currently exhibits a proliferating pipeline with 10+ therapeutic candidates.

Request to Get Free Sample Pages at: http://bit.ly/32UuEkB

Novartis AG, Biophytis SAS, Merck & Co. Inc., and Vibe Pharmaceuticals LLC are some of the major companies involved in development of therapeutics for sarcopenia.

Sjögren’s Syndrome Therapeutics – Pipeline Analysis, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments.

Request to Get Free Sample Pages at: http://bit.ly/2W1EgbV

According to a new research report “Sjögren’s Syndrome Therapeutics Pipeline Analysis, Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments” published by P&S Intelligence, Sjögren’s syndrome currently exhibits a pipeline of approximately 42 drug candidates.

Some of the key players developing drugs for Sjögren’s syndrome include Kissei Pharmaceutical Co., Ltd., UCB Group, Bristol-Myers Squibb Company and others.

’s

Bronchiectasis Therapeutics – Pipeline Analysis , Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by Pharma Proff, bronchiectasis therapeutics currently exhibits a proliferating pipeline with 10+ therapeutic candidates.

Request to Get the Sample Pages at: http://bit.ly/2wuk8UY

ARADIGM LIMITED , Bayer , Santhera Pharmaceuticals , Insmed Incorporated , Zambon , and Alitair Pharmaceuticals are some of the companies involved in the development of .

Benign Prostatic Hyperplasia (BPH) Therapeutics – Pipeline Analysis, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by Pharma Proff, the BPH therapeutics currently exhibits a proliferating pipeline with 15+ therapeutic candidates.

Request to Get the Sample Pages at: http://bit.ly/3bTvWR0

Sanofi , Abbott, Pfizer , Astellas Pharma US , Lilly and Company , Merck , Nymox Corporation , GSK are some of the key players involved in the development of therapeutic agents for ( ) .

Uveitis Therapeutics Pipeline Analysis , Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by Pharma Proff, uveitis therapeutics currently exhibits a proliferating pipeline with 15+ therapeutic candidates.

Request to Get the Sample Pages at: http://bit.ly/2SADsY5

Gilead Sciences , Santen , Aldeyra Therapeutics , Novartis , Bristol-Myers Squibb, AbbVie are some of the key players involved in the development of therapeutic drugs indicated for the treatment of .

Spinal Muscular Atrophy (SMA) Therapeutics – Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by , SMA therapeutics currently exhibits a proliferating pipeline with 15+ therapeutic candidates.

Request to Get Sample Pages at: http://bit.ly/39JnykY

Biogen , AveXis, Inc.,Roche, Cytokinetics , and are some of the key companies involved in the development of Spinal ( ) .
No alt text provided for this image

Request Sample - Spinal Muscular Atrophy (SMA) Therapeutics – Pipeline Analysis 2019

Hereditary Angioedema (HAE) Therapeutics – Pipeline Analysis , Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments”published by Pharma Proff, HAE therapeutics currently exhibits a proliferating pipeline with 20+ therapeutic candidates.

Request to Get Free Sample Pages at: http://bit.ly/2v11e7N

Pharming Group N.V. , Alnylam Pharmaceuticals , BioCryst Pharmaceuticals, Inc. , Ionis Pharmaceuticals, Inc. are some of the major players involved in the development of therapeutics for ( ) .

Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Analysis , Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments” published by Pharma Proff, COPD therapeutics currently exhibits a proliferating pipeline of 150+ therapeutic candidates.

Request to Get the Sample Pages at: http://bit.ly/38RTbbS

Theravance Biopharma US, Inc.MyLann .,AstraZeneca GSK are some of the major companies involved in the development of drug candidate for the treatment of ( ) .